Recruiting

Testing a new imaging tracer to detect fungal infections

Plain-English translation of NCT07704333 on ClinicalTrials.gov ↗ · Source last updated October 2026 · Translation generated October 2026 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

What is this trial?

Researchers are testing a new radioactive tracer called that may help detect serious fungal infections in the body. This tracer is used with a PET scan — a type of imaging test that shows where infections are located. The study will first test the tracer in healthy volunteers to confirm it's safe, then use it in people with known or suspected mold infections to see if it lights up the infected areas.

Serious fungal infections can be hard to find inside the body, and doctors often have to use guesswork or invasive tests to confirm them. This new imaging tracer could help doctors spot these infections faster and more accurately, leading to earlier treatment and better outcomes.

Do you qualify?

You likely qualify if…

you are 18 years of age or older
you are able to read, understand, and sign an informed consent form
you are willing and able to follow all study procedures
you are generally healthy (for healthy volunteer groups) OR you have a proven or probable invasive mold infection like aspergillosis or mucormycosis (for patient groups)
if you are a woman who could become pregnant, you are using an acceptable form of birth control

You likely don't qualify if…

you are unable to understand or consent to the study procedures
you are a woman who is pregnant or breastfeeding
you are too unstable or ill to participate safely (if hospitalized, your doctor must clear you first)
you cannot commit to attending study visits

What participation looks like

If you're a healthy volunteer, you'll receive an injection of the tracer and undergo a PET scan lasting about an hour, along with blood tests and safety monitoring. If you have a fungal infection, you'll receive the same injection and imaging scan to see if the tracer accumulates at the site of your infection. The entire study typically takes one visit, though some follow-up assessments may be needed to monitor your safety.

AI-generated summary from trial data · Oct 12, 2026 · Not medical advice

Testing a new imaging tracer to detect fungal infections

What is this trial?

Do you qualify?

What participation looks like

Trial locations(1 site)